Current Clinical Trials

Opthea

Palmetto Retina - Wednesday, March 21, 2018
OPT 302-1002: A dose-ranging study of intravitreal OPT-302 in combination with Ranibizumab, compared with Ranibizumab alone, in participants with Neovascular Age-Related Macular Degeneration (wet  Read More

National Eye Institute

Palmetto Retina - Wednesday, March 21, 2018
SCORE 2- 5 year follow up: Study of COmparative Treatments for Retinal Vein Occlusion 2 A multicenter, prospective, randomized non-inferiority trial of eyes with Macular Edema secondary to Central Read More

0

Combined Years of Practice

0

Operations Performed

0

Clinical Trials Participated

0

Offices

Our Physicians

Take a few moments to meet the skilled physicians of Palmetto Retina, P.A.

Please Contact Us For More Information

(803) 931-0077 | (888) 931-0077